U.S. Stock ETFs Pare Early Gains on Poor Coronavirus Drug Trial

U.S. markets and stock exchange traded funds pushed higher Thursday but pared earlier gains on reports of a failed clinical trial in the development of an antiviral for the coronavirus. On Thursday, the Invesco QQQ Trust (NASDAQ: QQQ) was flat, SPDR Dow Jones Industrial Average ETF (NYSEArca: DIA)...